|
|
my account
log out
|
Afuco™ Anti-Human CSPG4 ADCC Theraputic Antibody, ADCC Enhanced |
| Create: 08/09/2019 |
| Expired Date: | never |
| Category: | Drugs&Pharmaceutical [Health&Medical&Pharmaceutical] |
| Message: | Anti-CSPG4 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The antibodies bind to the membrane-proximal domain (MP) of human Melanoma-Associated Chondroitin Sulphate Proteoglycan (MCSP), and are capable of mediating cytolysis of a cell expressing MCSP in the presence of human effector cells or complement. They can be used to treat for the immunotherapy of melanoma. https://www.creativebiolabs.net/Anti-CSPG4-ADCC-Enhanced-Antibody-20488.htm |
![]() | |
| City: | Shirley[US]
|
| Location: |
|
| Feb 01 2023 | VBS++ (with Ca and Mg) Buffer | 269 | |
| Feb 01 2023 | GVBE Buffer | 277 | |
| Feb 01 2023 | GVB++ (with Ca and Mg) Buffer | 277 | |
| Feb 01 2023 | Hemolysin (Rabbit Anti-Sheep Cell Hemolysin) | 272 | |
| Aug 30 2019 | Anti-HSV-2 gH Antibody | 463 | |
| Aug 30 2019 | Anti-L. major LPG Antibody | 545 | |
| Aug 30 2019 | Anti-DENV-1 Antibody | 453 | |
| Aug 30 2019 | Anti-BPV-1 L1 Antibody | 467 | |
| Aug 30 2019 | Anti-H3N2 HA Antibody | 455 | |
| Aug 30 2019 | Anti-EIAV env Antibody | 476 |
| Copyright © toextrade Inc. All rights reserved. Contact us |